Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Head and Neck Cancer

Free Subscription 12.01.2026 4 Am J Surg 1 Ann Surg 2 BMC Cancer 1 Cancer 1 Clin Cancer Res 1 Clin Nucl Med 3 Head Neck 1 Int J Cancer 1 J Laryngol Otol 1 J Oral Maxillofac Surg 7 Laryngoscope 5 Ophthalmic Plast Reconstr Surg 2 Oral Oncol 1 Otolaryngol Head Neck Surg 2 PLoS One 1 Proc Natl Acad Sci U S A 3 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Surg

1. ROGERS JL, Henostroza S, Fahey A, Solorzano CC, et al
   Cost analysis in thyroid cancer clinical trials: Toward value-based oncology care.
   Am J Surg. 2026;252:116772.
   PubMed         Abstract available
   
   
2. SWAMINATHAN N, Song Z, Wu C, Akhund R, et al
   Diagnostic value of molecular testing for evaluating thyroid nodules greater than 4 centimeters.
   Am J Surg. 2026;252:116755.
   PubMed         Abstract available
   
   
3. LYON S, Turza A, Ganesan S, McHenry CR, et al
   Positive predictive value of the Afirma gene sequencing classifier for evaluation of the indeterminate thyroid nodule: An institutional experience.
   Am J Surg. 2026;252:116759.
   PubMed         Abstract available
   
   
4. MONTGOMERY KB, Rademacher N, Richman JS, Bhatia S, et al
   Healthcare facility volume and evidence-based practice implementation in surgical care of patients with common cancers.
   Am J Surg. 2026;252:116733.
   PubMed         Abstract available
   
   

   
   Ann Surg

5. O'NEILL LM, Guinan E, Doyle SL, Bennett AE, et al
   The RESTORE Randomized Controlled Trial: Impact of a Multidisciplinary Rehabilitative Program on Cardiorespiratory Fitness in Esophagogastric Cancer Survivorship: Erratum.
   Ann Surg. 2026;283:e5-e6.
   PubMed        
   
   

   
   BMC Cancer

6. ZHU Y, Chen T, Chen S, Bai G, et al
   A radiomics and machine learning-based method for dynamic assessment of tumor burden after neoadjuvant therapy in esophageal cancer.
   BMC Cancer. 2026 Jan 5. doi: 10.1186/s12885-025-15520.
   PubMed        
   
   
7. HE Y, Shuai R, Wu J, Zhou L, et al
   Unveiling the ITGbeta1-CLIC1 axis: a new frontier in oral squamous cell carcinoma progression and immune evasion: insights from the tumor-mimetic ECM system.
   BMC Cancer. 2025;26:8.
   PubMed         Abstract available
   
   

   
   Cancer

8. MEHTA R, Rivero-Hinojosa S, Dayyani F, Ferguson J, et al
   Circulating tumor DNA informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers.
   Cancer. 2026;132:e70242.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

9. HANNA GJ, Scarfo N, Shin KY, O'Neill A, et al
   Elraglusib, a Glycogen Synthase Kinase 3beta Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma.
   Clin Cancer Res. 2026;32:83-93.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

10. HUANG D, Ji Y, Jiang C, Zhang C, et al
    Extensive Intravenous Tumor Thrombus and Right Atrial Bland Thrombus From Poorly Differentiated Thyroid Cancer: 18F-FDG PET/CT Imaging Findings.
    Clin Nucl Med. 2025 Oct 29. doi: 10.1097/RLU.0000000000006154.
    PubMed         Abstract available
    
    

    
    Head Neck

11. JOSEPH JK, Stanisce L, Ramirez R, Kapustin D, et al
    Molecular Characterization of Isolated Soft Tissue Deposits in Papillary Thyroid Carcinoma.
    Head Neck. 2026 Jan 8. doi: 10.1002/hed.70142.
    PubMed         Abstract available
    
    
12. AHMADIAN D, Gallego CJ, Hurtado C, Tseng P, et al
    The Impact of p16 Status on Survival Within Non-Oropharyngeal Head and Neck Squamous Cell Carcinoma.
    Head Neck. 2026 Jan 6. doi: 10.1002/hed.70141.
    PubMed         Abstract available
    
    
13. ARBOLEDA LPA, de Abreu M, Pinto A, Moyses RA, et al
    Head and Neck Cancer Patients' Health Literacy: A Systematic Review and Meta-Analysis.
    Head Neck. 2026 Jan 5. doi: 10.1002/hed.70154.
    PubMed         Abstract available
    
    

    
    Int J Cancer

14. ZHANG M, Xie D, Hu Y, Qin G, et al
    Overdiagnosis of thyroid cancer in the United States: Improved estimates based on the SEER registries during 2000-2019.
    Int J Cancer. 2026;158:1215-1226.
    PubMed         Abstract available
    
    

    
    J Laryngol Otol

15. CHEN J
    N3 Nodal Disease as a Dominant Prognostic Determinant in Head and Neck Squamous Cell Carcinoma.
    J Laryngol Otol. 2026 Jan 5:1-3. doi: 10.1017/S0022215125104222.
    PubMed        
    
    

    
    J Oral Maxillofac Surg

16. LEE C, Wasay SA, Jenkins G, Moyer K, et al
    Patterns of Recurrence and Oncologic Outcomes After Maxillectomy: Does Reconstructive Modality Matter?
    J Oral Maxillofac Surg. 2026;84:115-126.
    PubMed         Abstract available
    
    

    
    Laryngoscope

17. MODI RN, Davis Mills M, Zeng DZ, Wang HY, et al
    Retrograde Parotidectomy Allowing Diagnosis of Parotid Lymphoma and Concomitant Facial Reanimation.
    Laryngoscope. 2026;136:197-201.
    PubMed         Abstract available
    
    
18. DALE M, Gabella G, Benzi P, Campagnari V, et al
    Primary Head and Neck Histiocytic Sarcoma of the Oropharyngeal Posterolateral Wall: A Case Report.
    Laryngoscope. 2026;136:240-242.
    PubMed         Abstract available
    
    
19. TRUONG AA, Ho S, Lee RH, Wu X, et al
    Perineural Invasion and Survival in Pembrolizumab-Treated Head and Neck Squamous Cell Carcinoma.
    Laryngoscope. 2026 Jan 3. doi: 10.1002/lary.70350.
    PubMed         Abstract available
    
    
20. BEHNAM-HANONA R, Patel N, Boscardin JW, Bhethanabotla RM, et al
    A Longitudinal Assessment of Patient Satisfaction Following Head and Neck Free Flap Reconstruction.
    Laryngoscope. 2026;136:190-196.
    PubMed         Abstract available
    
    
21. STEFANOVIC M, Hernando-Calvo A, Castro JB, Huang SH, et al
    Prognostic Factors in Sinonasal Cancers: A Multicenter Pooled Analysis.
    Laryngoscope. 2026;136:226-235.
    PubMed         Abstract available
    
    
22. PANARA K, Wilensky J, Workman AD, Lerner DK, et al
    MMP11 as a Prognostic Indicator for Inverted Papilloma Histologic Grade and Recurrence.
    Laryngoscope. 2026;136:113-118.
    PubMed         Abstract available
    
    
23. MOFFATT C, Pillutla P, Laklouk IA, Smith AF, et al
    Radiation Fibrosis of the Epiglottis: Histopathology and Multiphoton Imaging of Collagen and Elastin.
    Laryngoscope. 2026;136:340-350.
    PubMed         Abstract available
    
    

    
    Ophthalmic Plast Reconstr Surg

24. CHEN NA, Chen TH, Yuan S, Estopinal MDV, et al
    A Rare Case of Metastatic Papillary Thyroid Carcinoma Presenting as an Invasive Orbital Mass.
    Ophthalmic Plast Reconstr Surg. 2026 Jan 6. doi: 10.1097/IOP.0000000000003168.
    PubMed        
    
    
25. SIDHU AS, Herrera J, Jones MM, Habib R, et al
    Secondary Sinonasal Malignancies After Retinoblastoma.
    Ophthalmic Plast Reconstr Surg. 2025 Jun 20. doi: 10.1097/IOP.0000000000002958.
    PubMed         Abstract available
    
    
26. CHENG S, Roelofs KA
    Patterns of Basal Cell Carcinoma Presentation in the NIH All of Us Database.
    Ophthalmic Plast Reconstr Surg. 2026;42:40-44.
    PubMed         Abstract available
    
    
27. JUNTIPWONG S, Alizada M, Simmon K, Sarigul Sezenoz A, et al
    Review of the Management of Periocular Cutaneous Squamous Cell Carcinoma With Perineural Spread Over the Last Decade.
    Ophthalmic Plast Reconstr Surg. 2026;42:79-85.
    PubMed         Abstract available
    
    
28. MOHAMED Y, Al-Rawi AM, Al-Zaid T, Al-Faky YH, et al
    Solitary Fibrous Tumor of the Tarsus.
    Ophthalmic Plast Reconstr Surg. 2026;42:e13-e15.
    PubMed         Abstract available
    
    

    
    Oral Oncol

29. DAI WF, Nguyen L, Liu N, Chan KK, et al
    Real-world effectiveness and healthcare utilization of nivolumab for advanced head and neck cancer: A real-world population-based descriptive study.
    Oral Oncol. 2026;173:107851.
    PubMed         Abstract available
    
    
30. MARGONI A, Papavassiliou KA, Papavassiliou AG
    Harnessing TP53 mutational status to enhance prognostic precision and therapeutic effectiveness in head and neck squamous cell carcinoma.
    Oral Oncol. 2026;173:107846.
    PubMed        
    
    

    
    Otolaryngol Head Neck Surg

31. LIEN KH, Lin CY, Chen PY, Chang JT, et al
    Auditory Preservation in Nasopharyngeal Carcinoma: Comparison of Proton and Photon Radiotherapy.
    Otolaryngol Head Neck Surg. 2026 Jan 8. doi: 10.1002/ohn.70113.
    PubMed         Abstract available
    
    

    
    PLoS One

32. YU J, Zhang Y, Chen Z, Yang X, et al
    Exploring the role of resilience and quality of life in preoperative fear of cancer recurrence among patients with oral and maxillofacial cancer: A cross-sectional study.
    PLoS One. 2026;21:e0339329.
    PubMed         Abstract available
    
    
33. SCHWARZ S, Kummer S, Klang A, Walter I, et al
    Detection of vasculogenic mimicry in equine ocular, oronasal, and genital squamous cell carcinoma.
    PLoS One. 2026;21:e0328584.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

34. SU ZF, Wu CZ, Ding HR, Zhan Q, et al
    Spatially resolved multiomics reveals the self-enforcing property of the leading-edge multicellular ecosystem of head and neck cancer.
    Proc Natl Acad Sci U S A. 2026;123:e2519474123.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

35. MANDUCHI B, Jefferson TC, Moreno AC, Barbon CEA, et al
    Individual patient-reported symptom items discriminate imaging-graded dysphagia in head and neck cancer patients treated with radiotherapy: secondary analysis of pooled prospective studies.
    Radiother Oncol. 2026 Jan 6:111365. doi: 10.1016/j.radonc.2026.111365.
    PubMed         Abstract available
    
    
36. XU Q, Shen H, Wen L, Tu C, et al
    Development and validation of A CCTA-based risk prediction model for major adverse cardiovascular events in esophageal cancer patients receiving radiotherapy.
    Radiother Oncol. 2026 Jan 6:111364. doi: 10.1016/j.radonc.2026.111364.
    PubMed         Abstract available
    
    
37. CHEN B, Wang D, Huang J, Yu S, et al
    A seven-gene 5-hydroxymethylcytosine signature in circulating cell-free DNA for prognostic stratification of nasopharyngeal carcinoma.
    Radiother Oncol. 2026 Jan 5:111366. doi: 10.1016/j.radonc.2026.111366.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.